HUM-MOLGEN events: CHI's BLOOD PRODUCT SAFETY/ TSE PERCEPTION VS. REALITY

HUM-MOLGEN -> Events -> Meetings and Conferences

CHI's BLOOD PRODUCT SAFETY/ TSE PERCEPTION VS. REALITY

September 21, 2001

Cambridge Healthtech Institute, Marriott at Metro Center, Washington, DC
February 4-7, 2002

Blood Product Safety
February 4-6, 2002

Transmissible Spongiform Encephalopathies
February 6-7, 2002

Marriott at Metro Center, Washington, DC

Human blood, plasma and tissue contain many proteins, the extraction and purification of which are of great medical and economic importance. Transmission of infectious diseases via blood transfusion, tissue implantation and the use of processed blood plasma and components have placed a high priority on the development of new strategies for safeguarding the health of millions of patients who receive blood and tissue-derived products every year. The screening of blood for the detection of infectious agents is continuing to advance but is complicated by the presence new and emerging pathogens. In addition, cost-effectiveness and the threat of emerging and/or crossover infective agents must also be considered. Recent advances and new strategies for the inactivation and removal of infectious agents in whole blood, cord blood, component concentrates, plasma and tissue is the focal point of CHI's Eighth Annual Blood Product Safety conference.

Organized by:

Cambridge Healthtech Institute

Invited Speakers:

To be announced

Deadline for Abstracts:

January 4, 2002

Registration:

http://www.chidb.com/2002/bss/bss_form.htm

E-mail:

fvargus@healthtech.com

Posted by:

Frederick Vargus